Cosmos Health expands Oceania sales. Cosmos Health stock rose 3.16 percent on October 23

Cosmos Health expanded its e-commerce and subscription business to Australia, New Zealand and the broader Oceania region on October 22, 2026, according to StockTitan. Cosmos Health stock rose 3.16 percent on Nasdaq and closed at USD 0.26 on October 23, 2026 at 4:00 p.m. EDT.

Subscription sales move overseas

The Oceania rollout extends the direct-to-consumer model that had 8,940 active U.S. subscriptions and 14,624 online checkout orders as of October 19, 2026. StockTitan reported that sales were already underway in Australia, New Zealand and the broader region, with recurring delivery available through the company's online stores.

The operating base is expanding quickly. The company had 8,940 active U.S. subscriptions on October 19, 2026, compared with 6,287 five days earlier, while the October 22 release described the international launch as the next step in its broader recurring-revenue strategy.

Price position and valuation

Cosmos Health's Nasdaq closing price was USD 0.26 on October 23, 2026, up 3.16 percent on the session. The same quote page showed a day range of USD 0.24 to USD 0.28, a 52-week range of USD 0.16 to USD 1.05, year-to-date performance of minus 47.59 percent and volume of 2.68 million shares.

Market value stood at USD 26.27 million on October 23, 2026. The Nasdaq listing and COSM ticker are identified in the company's October 20 shareholder update carried by Morningstar.

Revenue and the next date

In the second quarter of 2026, revenue reached USD 19.32 million versus a USD 18.99 million consensus estimate, while GAAP earnings per share were minus USD 0.10 against a minus USD 0.10 consensus estimate, according to MarketBeat. The figures came from the quarter reported on August 18, 2026.

MarketBeat lists November 13, 2026 as the estimated next earnings date, with a consensus revenue estimate of USD 17.28 million and consensus earnings per share of minus USD 0.06. The site also notes that the date is based on past reporting schedules.

Comparison with peers

Cosmos Health: up 3.16 percent, P/E minus 0.40, market capitalization USD 26.27 million.

McKesson Corporation (NYSE, USD): down 1.14 percent, P/E 26.78, market capitalization USD 116.7 billion.

Cencora (NYSE, USD): down 2.21 percent, P/E 24.59, market capitalization USD 63.2 billion.

Stock closes after the rollout

Cosmos Health combines pharmaceutical distribution, contract manufacturing, proprietary brands and direct-to-consumer sales. The Oceania launch adds geographic reach to a subscription model that was already scaling in the United States.

Cosmos Health stock closed at USD 0.26 on Nasdaq on October 23, 2026 at 4:00 p.m. EDT, up 3.16 percent on the day.

Market context: Market report Nasdaq Composite.

More news and analyses on Cosmos Health stock